Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Benign Prostatic Hyperplasia (BPH) Treatment Devices market in any manner.
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Advin Urology
Biolitec
Boston Scientific Corporation
CONMED
Convergent Laser Technologies
CoreTherm Medical, Inc. (ProstaLund)
HistoSonics, Inc.
JenaSurgical GmbH
KARL STORZ
LISA Laser Products GmbH
Lumenis Ltd.
Medifocus, Inc.
Endo International
Medtronic
Siemens
Olympus
Urologix
NeoTract
Urotech
Baxter International
Market Segmentation (by Type)
Surgical Treatment
Minimally Invasive Treatment
Laser Treatment
Other
Market Segmentation (by Application)
Fertility Clinics
Hospitals
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Benign Prostatic Hyperplasia (BPH) Treatment Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Benign Prostatic Hyperplasia (BPH) Treatment Devices market in any manner.
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Advin Urology
Biolitec
Boston Scientific Corporation
CONMED
Convergent Laser Technologies
CoreTherm Medical, Inc. (ProstaLund)
HistoSonics, Inc.
JenaSurgical GmbH
KARL STORZ
LISA Laser Products GmbH
Lumenis Ltd.
Medifocus, Inc.
Endo International
Medtronic
Siemens
Olympus
Urologix
NeoTract
Urotech
Baxter International
Market Segmentation (by Type)
Surgical Treatment
Minimally Invasive Treatment
Laser Treatment
Other
Market Segmentation (by Application)
Fertility Clinics
Hospitals
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Benign Prostatic Hyperplasia (BPH) Treatment Devices Market
- Overview of the regional outlook of the Benign Prostatic Hyperplasia (BPH) Treatment Devices Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Benign Prostatic Hyperplasia (BPH) Treatment Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.2 Key Market Segments
1.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
1.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers (2019-2024)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Sites, Area Served, Product Type
3.6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Situation and Trends
3.6.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Benign Prostatic Hyperplasia (BPH) Treatment Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2019-2024)
6.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Market Share by Type (2019-2024)
6.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2019-2024)
7 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales by Application (2019-2024)
7.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Application (2019-2024)
8 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Advin Urology
9.1.1 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.1.2 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.1.4 Advin Urology Business Overview
9.1.5 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
9.1.6 Advin Urology Recent Developments
9.2 Biolitec
9.2.1 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.2.2 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.2.4 Biolitec Business Overview
9.2.5 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
9.2.6 Biolitec Recent Developments
9.3 Boston Scientific Corporation
9.3.1 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.3.2 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
9.3.5 Boston Scientific Corporation Business Overview
9.3.6 Boston Scientific Corporation Recent Developments
9.4 CONMED
9.4.1 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.4.2 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.4.4 CONMED Business Overview
9.4.5 CONMED Recent Developments
9.5 Convergent Laser Technologies
9.5.1 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.5.2 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.5.4 Convergent Laser Technologies Business Overview
9.5.5 Convergent Laser Technologies Recent Developments
9.6 CoreTherm Medical, Inc. (ProstaLund)
9.6.1 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.6.2 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.6.4 CoreTherm Medical, Inc. (ProstaLund) Business Overview
9.6.5 CoreTherm Medical, Inc. (ProstaLund) Recent Developments
9.7 HistoSonics, Inc.
9.7.1 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.7.2 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.7.4 HistoSonics, Inc. Business Overview
9.7.5 HistoSonics, Inc. Recent Developments
9.8 JenaSurgical GmbH
9.8.1 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.8.2 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.8.4 JenaSurgical GmbH Business Overview
9.8.5 JenaSurgical GmbH Recent Developments
9.9 KARL STORZ
9.9.1 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.9.2 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.9.4 KARL STORZ Business Overview
9.9.5 KARL STORZ Recent Developments
9.10 LISA Laser Products GmbH
9.10.1 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.10.2 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.10.4 LISA Laser Products GmbH Business Overview
9.10.5 LISA Laser Products GmbH Recent Developments
9.11 Lumenis Ltd.
9.11.1 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.11.4 Lumenis Ltd. Business Overview
9.11.5 Lumenis Ltd. Recent Developments
9.12 Medifocus, Inc.
9.12.1 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.12.4 Medifocus, Inc. Business Overview
9.12.5 Medifocus, Inc. Recent Developments
9.13 Endo International
9.13.1 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.13.4 Endo International Business Overview
9.13.5 Endo International Recent Developments
9.14 Medtronic
9.14.1 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.14.2 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.14.4 Medtronic Business Overview
9.14.5 Medtronic Recent Developments
9.15 Siemens
9.15.1 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.15.2 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.15.4 Siemens Business Overview
9.15.5 Siemens Recent Developments
9.16 Olympus
9.16.1 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.16.2 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.16.4 Olympus Business Overview
9.16.5 Olympus Recent Developments
9.17 Urologix
9.17.1 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.17.2 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.17.4 Urologix Business Overview
9.17.5 Urologix Recent Developments
9.18 NeoTract
9.18.1 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.18.2 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.18.4 NeoTract Business Overview
9.18.5 NeoTract Recent Developments
9.19 Urotech
9.19.1 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.19.2 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.19.4 Urotech Business Overview
9.19.5 Urotech Recent Developments
9.20 Baxter International
9.20.1 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.20.2 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.20.4 Baxter International Business Overview
9.20.5 Baxter International Recent Developments
10 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET FORECAST BY REGION
10.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast
10.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country
10.2.3 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region
10.2.4 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2025-2030)
11.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2025-2030)
11.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Application (2025-2030)
11.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application
11.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
1.2 Key Market Segments
1.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
1.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Manufacturers (2019-2024)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Sites, Area Served, Product Type
3.6 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competitive Situation and Trends
3.6.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Benign Prostatic Hyperplasia (BPH) Treatment Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2019-2024)
6.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Market Share by Type (2019-2024)
6.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2019-2024)
7 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales by Application (2019-2024)
7.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Application (2019-2024)
8 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET SEGMENTATION BY REGION
8.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Advin Urology
9.1.1 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.1.2 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.1.4 Advin Urology Business Overview
9.1.5 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
9.1.6 Advin Urology Recent Developments
9.2 Biolitec
9.2.1 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.2.2 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.2.4 Biolitec Business Overview
9.2.5 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
9.2.6 Biolitec Recent Developments
9.3 Boston Scientific Corporation
9.3.1 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.3.2 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
9.3.5 Boston Scientific Corporation Business Overview
9.3.6 Boston Scientific Corporation Recent Developments
9.4 CONMED
9.4.1 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.4.2 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.4.4 CONMED Business Overview
9.4.5 CONMED Recent Developments
9.5 Convergent Laser Technologies
9.5.1 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.5.2 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.5.4 Convergent Laser Technologies Business Overview
9.5.5 Convergent Laser Technologies Recent Developments
9.6 CoreTherm Medical, Inc. (ProstaLund)
9.6.1 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.6.2 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.6.4 CoreTherm Medical, Inc. (ProstaLund) Business Overview
9.6.5 CoreTherm Medical, Inc. (ProstaLund) Recent Developments
9.7 HistoSonics, Inc.
9.7.1 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.7.2 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.7.4 HistoSonics, Inc. Business Overview
9.7.5 HistoSonics, Inc. Recent Developments
9.8 JenaSurgical GmbH
9.8.1 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.8.2 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.8.4 JenaSurgical GmbH Business Overview
9.8.5 JenaSurgical GmbH Recent Developments
9.9 KARL STORZ
9.9.1 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.9.2 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.9.4 KARL STORZ Business Overview
9.9.5 KARL STORZ Recent Developments
9.10 LISA Laser Products GmbH
9.10.1 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.10.2 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.10.4 LISA Laser Products GmbH Business Overview
9.10.5 LISA Laser Products GmbH Recent Developments
9.11 Lumenis Ltd.
9.11.1 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.11.4 Lumenis Ltd. Business Overview
9.11.5 Lumenis Ltd. Recent Developments
9.12 Medifocus, Inc.
9.12.1 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.12.4 Medifocus, Inc. Business Overview
9.12.5 Medifocus, Inc. Recent Developments
9.13 Endo International
9.13.1 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.13.4 Endo International Business Overview
9.13.5 Endo International Recent Developments
9.14 Medtronic
9.14.1 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.14.2 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.14.4 Medtronic Business Overview
9.14.5 Medtronic Recent Developments
9.15 Siemens
9.15.1 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.15.2 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.15.4 Siemens Business Overview
9.15.5 Siemens Recent Developments
9.16 Olympus
9.16.1 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.16.2 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.16.4 Olympus Business Overview
9.16.5 Olympus Recent Developments
9.17 Urologix
9.17.1 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.17.2 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.17.4 Urologix Business Overview
9.17.5 Urologix Recent Developments
9.18 NeoTract
9.18.1 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.18.2 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.18.4 NeoTract Business Overview
9.18.5 NeoTract Recent Developments
9.19 Urotech
9.19.1 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.19.2 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.19.4 Urotech Business Overview
9.19.5 Urotech Recent Developments
9.20 Baxter International
9.20.1 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
9.20.2 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
9.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Market Performance
9.20.4 Baxter International Business Overview
9.20.5 Baxter International Recent Developments
10 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES MARKET FORECAST BY REGION
10.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast
10.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country
10.2.3 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region
10.2.4 South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2025-2030)
11.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2025-2030)
11.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Application (2025-2030)
11.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application
11.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Comparison by Region (M USD)
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2022)
Table 10. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Sites and Area Served
Table 12. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Challenges
Table 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (K Units)
Table 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Type (M USD)
Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2019-2024)
Table 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Share by Type (2019-2024)
Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application
Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Application
Table 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2019-2024)
Table 33. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application (2019-2024)
Table 35. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2019-2024)
Table 38. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 43. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 44. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 45. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Advin Urology Business Overview
Table 47. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
Table 48. Advin Urology Recent Developments
Table 49. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 50. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 51. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Biolitec Business Overview
Table 53. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
Table 54. Biolitec Recent Developments
Table 55. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 56. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 57. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
Table 59. Boston Scientific Corporation Business Overview
Table 60. Boston Scientific Corporation Recent Developments
Table 61. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 62. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 63. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. CONMED Business Overview
Table 65. CONMED Recent Developments
Table 66. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 67. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 68. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Convergent Laser Technologies Business Overview
Table 70. Convergent Laser Technologies Recent Developments
Table 71. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 72. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 73. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. CoreTherm Medical, Inc. (ProstaLund) Business Overview
Table 75. CoreTherm Medical, Inc. (ProstaLund) Recent Developments
Table 76. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 77. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 78. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. HistoSonics, Inc. Business Overview
Table 80. HistoSonics, Inc. Recent Developments
Table 81. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 82. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 83. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. JenaSurgical GmbH Business Overview
Table 85. JenaSurgical GmbH Recent Developments
Table 86. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 87. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 88. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. KARL STORZ Business Overview
Table 90. KARL STORZ Recent Developments
Table 91. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 92. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 93. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. LISA Laser Products GmbH Business Overview
Table 95. LISA Laser Products GmbH Recent Developments
Table 96. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 97. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 98. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Lumenis Ltd. Business Overview
Table 100. Lumenis Ltd. Recent Developments
Table 101. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 102. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 103. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Medifocus, Inc. Business Overview
Table 105. Medifocus, Inc. Recent Developments
Table 106. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 107. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 108. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Endo International Business Overview
Table 110. Endo International Recent Developments
Table 111. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 112. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 113. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Medtronic Business Overview
Table 115. Medtronic Recent Developments
Table 116. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 117. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 118. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Siemens Business Overview
Table 120. Siemens Recent Developments
Table 121. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 122. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 123. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Olympus Business Overview
Table 125. Olympus Recent Developments
Table 126. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 127. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 128. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Urologix Business Overview
Table 130. Urologix Recent Developments
Table 131. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 132. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 133. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. NeoTract Business Overview
Table 135. NeoTract Recent Developments
Table 136. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 137. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 138. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Urotech Business Overview
Table 140. Urotech Recent Developments
Table 141. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 142. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 143. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Baxter International Business Overview
Table 145. Baxter International Recent Developments
Table 146. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Comparison by Region (M USD)
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia (BPH) Treatment Devices as of 2022)
Table 10. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Sites and Area Served
Table 12. Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Challenges
Table 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (K Units)
Table 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Type (M USD)
Table 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Type (2019-2024)
Table 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2019-2024)
Table 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) by Type (2019-2024)
Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Share by Type (2019-2024)
Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (USD/Unit) by Type (2019-2024)
Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) by Application
Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Application
Table 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2019-2024) & (K Units)
Table 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2019-2024)
Table 33. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2019-2024) & (M USD)
Table 34. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application (2019-2024)
Table 35. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Application (2019-2024)
Table 36. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 37. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2019-2024)
Table 38. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 39. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 41. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 43. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 44. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 45. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Advin Urology Business Overview
Table 47. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
Table 48. Advin Urology Recent Developments
Table 49. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 50. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 51. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Biolitec Business Overview
Table 53. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
Table 54. Biolitec Recent Developments
Table 55. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 56. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 57. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices SWOT Analysis
Table 59. Boston Scientific Corporation Business Overview
Table 60. Boston Scientific Corporation Recent Developments
Table 61. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 62. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 63. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. CONMED Business Overview
Table 65. CONMED Recent Developments
Table 66. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 67. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 68. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Convergent Laser Technologies Business Overview
Table 70. Convergent Laser Technologies Recent Developments
Table 71. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 72. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 73. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. CoreTherm Medical, Inc. (ProstaLund) Business Overview
Table 75. CoreTherm Medical, Inc. (ProstaLund) Recent Developments
Table 76. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 77. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 78. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. HistoSonics, Inc. Business Overview
Table 80. HistoSonics, Inc. Recent Developments
Table 81. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 82. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 83. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. JenaSurgical GmbH Business Overview
Table 85. JenaSurgical GmbH Recent Developments
Table 86. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 87. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 88. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. KARL STORZ Business Overview
Table 90. KARL STORZ Recent Developments
Table 91. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 92. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 93. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. LISA Laser Products GmbH Business Overview
Table 95. LISA Laser Products GmbH Recent Developments
Table 96. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 97. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 98. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Lumenis Ltd. Business Overview
Table 100. Lumenis Ltd. Recent Developments
Table 101. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 102. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 103. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Medifocus, Inc. Business Overview
Table 105. Medifocus, Inc. Recent Developments
Table 106. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 107. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 108. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Endo International Business Overview
Table 110. Endo International Recent Developments
Table 111. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 112. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 113. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Medtronic Business Overview
Table 115. Medtronic Recent Developments
Table 116. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 117. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 118. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Siemens Business Overview
Table 120. Siemens Recent Developments
Table 121. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 122. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 123. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Olympus Business Overview
Table 125. Olympus Recent Developments
Table 126. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 127. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 128. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Urologix Business Overview
Table 130. Urologix Recent Developments
Table 131. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 132. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 133. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. NeoTract Business Overview
Table 135. NeoTract Recent Developments
Table 136. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 137. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 138. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Urotech Business Overview
Table 140. Urotech Recent Developments
Table 141. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Basic Information
Table 142. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Overview
Table 143. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Baxter International Business Overview
Table 145. Baxter International Recent Developments
Table 146. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD), 2019-2030
Figure 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) (2019-2030)
Figure 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country (M USD)
Figure 11. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers in 2023
Figure 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers in 2023
Figure 13. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type
Figure 18. Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2019-2024)
Figure 19. Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type in 2023
Figure 20. Market Size Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application
Figure 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application in 2023
Figure 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application (2019-2024)
Figure 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application in 2023
Figure 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2023
Figure 32. U.S. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2023
Figure 37. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2023
Figure 44. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (K Units)
Figure 50. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2023
Figure 51. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD), 2019-2030
Figure 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (M USD) (2019-2030)
Figure 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country (M USD)
Figure 11. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Manufacturers in 2023
Figure 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Manufacturers in 2023
Figure 13. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Benign Prostatic Hyperplasia (BPH) Treatment Devices Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Type
Figure 18. Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2019-2024)
Figure 19. Sales Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type in 2023
Figure 20. Market Size Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type (2019-2024)
Figure 21. Market Size Market Share of Benign Prostatic Hyperplasia (BPH) Treatment Devices by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application
Figure 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2019-2024)
Figure 25. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application in 2023
Figure 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application (2019-2024)
Figure 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Application in 2023
Figure 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate by Application (2019-2024)
Figure 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2019-2024)
Figure 30. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2023
Figure 32. U.S. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2023
Figure 37. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2023
Figure 44. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (K Units)
Figure 50. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2023
Figure 51. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Type (2025-2030)
Figure 65. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2025-2030)
Figure 66. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Forecast by Application (2025-2030)
